Supreme Court to hear case on conversion therapy ban in Colorado
UC Law professor weighs in on the discussion
The United States Supreme Court will hear arguments this week into a case challenging the legality of Colorado’s ban on conversion therapy impacting lesbians, gays and trans people, reports Newsweek.
Nearly two dozen states have banned conversion therapy for minors. Opponents of the therapy, which includes many medical professionals, say the practice of trying to change a person's sexual orientation or gender identity through counseling won’t work, isn’t backed by science and can harm minors.
Others argue that the law violates the First Amendment rights of counselors practicing conversion therapy. This could have implications for states that have sought to prohibit the practice. The Chiles v. Salazar case centers around Colorado counselor Kaley Chiles who challenged a Colorado law barring conversion therapy for minors.
Newsweek spoke with Ryan Thoreson, an associate professor at the University of Cincinnati College of Law, about the case. Some legal experts think the Supreme Court could end up overturning Colorado’s ban.
At UC Law, Thoreson’s scholarship examines the legal and social regulation of gender and sexuality and spans constitutional law, comparative and international law, and human rights law.
Read the Newsweek article online.
Learn more about UC’s Ryan Thoreson online.
Related Stories
Can ChatGPT help holiday shoppers?
December 5, 2025
Holiday shopping can be difficult. That’s why WLWT turned to Lindner College of Business professor Sachin Modi for insights on if large language models like ChatGPT can be helpful in finding more tailored gifts for loved ones.
Can new research improve the safety of AI therapy for teens?
December 5, 2025
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition for a discussion on the growing trend of young people turning to artificial intelligence for mental health support and therapy.
What would expanded access to GLP-1s mean for the obesity rate?
December 4, 2025
The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.